<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"
  dtd-version="1.3" xml:lang="en" article-type="research-article">
  <?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
  <?DTDIdentifier.IdentifierType public?>
  <?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
  <?SourceDTD.Version 1.2?>
  <?ConverterInfo.XSLTName jats2jats3.xsl?>
  <?ConverterInfo.Version 1?>
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="iso-abbrev">Pharmacophore</journal-id>
      <journal-id journal-id-type="publisher-id">pharmacophorejournal.com</journal-id>
      <journal-id journal-id-type="publisher-id">Pharmacophore</journal-id>
      <journal-title-group>
        <journal-title>Pharmacophore</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2229-5402</issn>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">pharmacophorejournal.com-6989</article-id>
      <article-id pub-id-type="doi">10.51847/H5FK3a0ddQ</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original research</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Why Artificial Intelligence–Enabled Medication Decision Support Becomes Useful, Ignored, or Routinely Overridden: A Realist Review of Workflow Conditions, Professional Trust, and Organizational Responses</article-title>
      </title-group>
                    <contrib-group>
                      <contrib contrib-type="author">
              <name>
                <surname>Berger</surname>
                <given-names>Thomas</given-names>
              </name>
                              <xref rid="aff1" ref-type="aff">1</xref>
                                                            <xref rid="cor1" ref-type="corresp" />
                          </contrib>
                      <contrib contrib-type="author">
              <name>
                <surname>Rahman</surname>
                <given-names>Nadia</given-names>
              </name>
                              <xref rid="aff2" ref-type="aff">2</xref>
                                        </contrib>
                      <contrib contrib-type="author">
              <name>
                <surname>Meyer</surname>
                <given-names>Lucas</given-names>
              </name>
                              <xref rid="aff3" ref-type="aff">3</xref>
                                        </contrib>
                      <contrib contrib-type="author">
              <name>
                <surname>Khalil</surname>
                <given-names>Rania</given-names>
              </name>
                              <xref rid="aff4" ref-type="aff">4</xref>
                                        </contrib>
                  </contrib-group>
                  <aff id="aff1">
            <label>1</label>Department of Clinical Pharmacy and AI Decision Support, University of Bern, Bern, Switzerland.
          </aff>
                  <aff id="aff2">
            <label>2</label>Department of Pharmacy Practice and Professional Trust, University of Dhaka, Dhaka, Bangladesh.
          </aff>
                  <aff id="aff3">
            <label>3</label>Department of Pharmaceutical Care and Health Informatics, University of Amsterdam, Amsterdam, Netherlands.
          </aff>
                  <aff id="aff4">
            <label>4</label>Department of Clinical Pharmacy and Organizational Behavior, Cairo University, Cairo, Egypt.
          </aff>
                          <author-notes>
            <corresp id="cor1">
              <bold>Address for correspondence:</bold> Prof. Wael Abu Dayyih, Department of
              Pharmaceutical Chemistry, Faculty of Pharmacy, Mutah University, Al-Karak 61710, Jordan.
                              E-mail: <email xlink:href="thomas.berger@unibe.ch">thomas.berger@unibe.ch</email>
                          </corresp>
          </author-notes>
                    <pub-date pub-type="epub">
        <day>28</day>
        <month>10</month>
        <year>2026</year>
      </pub-date>
      <volume>17</volume>
      <issue>5</issue>
      <fpage>63</fpage>
      <lpage>73</lpage>
      <permissions>
        <copyright-statement>
          Copyright: &#x000a9; 2026 Pharmacophore
        </copyright-statement>
        <copyright-year>2026</copyright-year>
        <license>
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/"
            specific-use="textmining" content-type="ccbyncsalicense">
            https://creativecommons.org/licenses/by-nc-sa/4.0/</ali:license_ref>
          <license-p>This is an open access journal, and articles are distributed under the terms of
            the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows
            others to remix, tweak, and build upon the work non-commercially, as long as appropriate
            credit is given and the new creations are licensed under the identical terms.</license-p>
        </license>
      </permissions>
      <abstract>
        <title>A<sc>BSTRACT</sc></title>
        <p>Artificial intelligence (AI)–enabled medication decision support can improve the identification and prioritization of prescribing risks, yet recommendations may be used selectively, ignored, or routinely overridden. These responses have different clinical meanings that cannot be determined from acceptance rates alone. This realist review examines how workflow conditions, professional trust, and organizational responses interact to shape medication decision-support use. Peer-reviewed literature published between 2018 and 2026 was identified through targeted scholarly searching and mapped against an initial programme theory. Context–mechanism–outcome reasoning was used to distinguish system characteristics, clinician interpretation, and observable actions. The evidence indicates that algorithmic performance, perceived relevance, interruption burden, professional accountability, and institutional implementation practices are distinct considerations in understanding medication-support behavior. It also identifies important differences between medication-alert studies, simulated human–AI decisions, and real-world implementation evaluations. However, complete record-level screening denominators and included-evidence-unit linkage were not recoverable from the search record, limiting final selection-flow reporting and confidence in a comprehensive synthesis. The explanatory account therefore remains conditional: useful uptake requires a combination of clinically relevant advice, workable opportunities for interpretation, and organizational arrangements that preserve professional judgment.  Override and non-use require contextual evaluation because they may represent appropriate clinical reasoning, adaptation to workflow constraints, or failure of implementation.</p>
      </abstract>
      <kwd-group>
                <kwd>Artificial intelligence</kwd>
                <kwd>Medication decision support</kwd>
                <kwd>Realist review</kwd>
                <kwd>Alert override</kwd>
                <kwd>Professional trust</kwd>
                <kwd>Clinical workflow</kwd>
              </kwd-group>
    </article-meta>
  </front>
</article>
